UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 6-K

REPORT OF FOREIGN PRIVATE ISSUER

PURSUANT TO RULE 13a-16 OR 15d-16 OF
THE SECURITIES EXCHANGE ACT OF 1934

For the month of July 2017

Commission File No. 00-30082

MERUS LABS INTERNATIONAL INC.
(Translation of registrant's name into English)

100 Wellington St. West, Suite 2110 P.O. Box 151
Toronto, ON M5K 1H1
(Address of principal executive office)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F
Form 20-F [ ] Form 40-F [X]

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1) [ ]

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7) [ ]

SUBMITTED HEREWITH

Exhibits 99.1 News release dated July 3, 2017 re: Merus Labs International Inc. and Norgine B.V. receive Spanish anti-trust approval of proposed Arrangement.

Exhibits
99.1	News release dated July 10, 2017 re: Merus Labs International Inc. Shareholders Approve Plan of Arrangement with Norgine B.V.
99.2	Report of Voting Results

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

Date: July 710, 2017 MERUS LABS INTERNATIONAL INC. /s/ Dr. Michael Bumby Dr. Michael Bumby Chief Financial Officer

MERUS LABS INTERNATIONAL INC.

/s/ Dr. Michael Bumby ______________________________________Dr. Michael Bumby Chief Financial Officer

Filing Compare · Merus Labs International Inc.